- Presentations
- 3
- Markets
- 1
Lunesta is a brand of Eszopiclone marketed by Waylis Therapeutics, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Eszopiclone
- Brand owner
- Waylis Therapeutics
- Registered in
- United States
- Strengths and forms
- 1 mg tablet, 2 mg tablet, 3 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lunesta 1 mg tabletOral | Waylis Therapeutics | US FDA | Available on request |
| Lunesta 2 mg tabletOral | Waylis Therapeutics | US FDA | Available on request |
| Lunesta 3 mg tabletOral | Waylis Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lunesta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.